Will Covid kick malaria out of the global bucket list? Michael Jennings Filed on May 3, 2021 Malaria is an example of where the needs of the Global South, or developing world, clash against the interests of the Global North, or developed world. Lost in the deluge of news about Covid-19 vaccines have been the momentous strides made recently in fighting other major health challenges. Among these is malaria. In April, it was announced that a vaccine developed at the University of Oxford’s Jenner Institute had achieved 77 per cent efficacy in trials. While we may still be several years from an effective guard against a disease that afflicts over 200 million people each year, there is a sense that we’re significantly closer to that goal than ever before. Yet, the vaccine’s very potential to successfully eradicate malaria could, perversely, undercut the support necessary to achieve reality. Malaria is an example of where the needs of the Global South, or developing world, clash against the interests of the Global North, or developed world.